You are here:
Two key factors set the GAVI Alliance apart from other actors in the field of international health aid:
In this section, we explain GAVI’s unique business model and the six ways it delivers "added value".
Donor and developing countries need to see proof of the value of new vaccines before investing.
Immunisation is a commitment for life that requires guaranteed, long-term funding.
Developing countries decide for themselves how best to use GAVI support for immunisation.
It's not enough to buy new vaccines. They have to safely reach every child.
Manufacturers will only make vaccines for poor countries if they know they can sell them .
National immunisation programes must survive long after GAVI support stops.
The Accelerated Vaccine Introduction Initiative is a showcase of the GAVI business model at work.
Since its launch in 2000, GAVI support has resulted in the immunisation of 124 million children with the Haemophilus influenzae type b vaccine.
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
03 May 2013
'Manipulation' of vaccination fears
BBC News/Seth Berkley
25 April 2013
India anti-polio campaign a model for other countries to follow
Haiti rebuilds with a foundation of vaccines
24 April 2013
The power of vaccines(2)
Philanthropy Age/Seth Berkley
23 April 2013
Every child deserves a healthy start in life
Al Arabiya/Seth Berkley
New vaccine introductions mark World Immunization Week
22 April 2013
New vaccine protects Haitian children from five diseases
Mozambique rolls out new pneumococcal vaccines
18 April 2013
Indian Firm Cuts Price of Major Vaccine
Voice of America
© GAVI Alliance 2013
modal window here